Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kangfuxin enteric-coated capsules plus mesalazine in mild-to-moderate ulcerative colitis
CTR20212997Phase 2Completed
- Sponsor
- Jingxin Pharmaceutical
- Start
- Dec 2021
- Countries
- 1
01
Overview
A Phase 2 trial of kangfuxin enteric-coated capsule in autoimmune colitis, sponsored by Jingxin Pharmaceutical. Started Dec 2021; status: completed.
02
Drugs
kangfuxin enteric-coated capsule
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20212997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212997.